Verified July 2026 · Cited to primary sources
MOTS-c vs Epitalon — evidence grades compared.
The honest verdict
MOTS-c and Epitalon sit at the same evidence tier — both Grade D (animal studies only, unproven in humans).
Both are Grade D with no rigorous human efficacy data, so neither is proven. They target different goals — MOTS-c is marketed as a metabolic "exercise mimetic," Epitalon as a longevity/anti-aging peptide — but the honest verdict is the same: the claims for both rest on preclinical or small, low-quality studies, not controlled human trials.
MOTS-c vs Epitalon: side by side
| Compared on | MOTS-c | Epitalon |
|---|---|---|
| Evidence grade | Grade D | Grade D |
| Legal status | Under FDA review | Under FDA review |
| Safety | Limited human safety data, no major documented harms | Limited human safety data, no major documented harms |
| Primary use | Weight Loss | Sleep |
| Typical cost | UNKNOWN | UNKNOWN |
| One-line verdict | MOTS-c is not FDA-approved and is under FDA review (July 23, 2026 PCAC). Human evidence is Grade D — metabolic effects are mostly preclinical, with human data limited to associations. For actual weight loss, an approved GLP-1 is the evidence-backed route. | Epitalon is not FDA-approved and is under FDA review (July 24, 2026 PCAC). Human evidence is Grade D — the longevity and anti-aging claims rest on small, low-quality Russian studies. |
| Full review | Full MOTS-c review → | Full Epitalon review → |
Grades and legal status are assigned by our evidence rubric, not by what we can sell. Highlighted cells mark the stronger-evidence side.
Trying to lose weight?
For weight loss, an approved GLP-1 beats either of these.
Neither peptide here has proven, legally-available weight-loss data that beats an approved GLP-1. Our sister site compares the options that actually work.
Medical disclaimer: This page is independent editorial information, not medical advice, and Best Peptide For That is not a medical provider. We do not provide dosing. Talk to a licensed clinician before starting, stopping, or changing any peptide or medication. Full medical disclaimer.
FAQ
MOTS-c vs Epitalon FAQ
Is MOTS-c better than Epitalon?
Neither is clearly better on evidence — MOTS-c and Epitalon are both Grade D (animal studies only, unproven in humans). Both are Grade D with no rigorous human efficacy data, so neither is proven. They target different goals — MOTS-c is marketed as a metabolic "exercise mimetic," Epitalon as a longevity/anti-aging peptide — but the honest verdict is the same: the claims for both rest on preclinical or small, low-quality studies, not controlled human trials.
Which has stronger human evidence, MOTS-c or Epitalon?
MOTS-c and Epitalon sit at the same evidence tier — both Grade D (animal studies only, unproven in humans). We grade every peptide A–F by strength of human evidence: MOTS-c is Grade D (animal studies only, unproven in humans) and Epitalon is Grade D (animal studies only, unproven in humans).
Is MOTS-c or Epitalon legal to get?
MOTS-c: regulatory limbo — july 2026 pcac vote pending (Under FDA review — July 2026 PCAC). Epitalon: regulatory limbo — july 2026 pcac vote pending (Under FDA review — July 2026 PCAC). Always confirm current status with a licensed clinician before pursuing either — we don't link gray-market vendors.
Keep comparing
The monthly peptide evidence brief.
What the research and the FDA actually say — one short email a month. Unsubscribe anytime.
No spam. We never sell your email. Editorial policy.